Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -6 of 6 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 2/1/1991


1.		Phase I Trial of Tetraplatin Administered Daily for Five Consecutive Days Every 28 Days in Patients with Metastatic Cancer (Summary Last Modified 02/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				over 18				NCI				UTHSC-8905011149 NCI-T89-0234C, T89-0234

Last Modified: 12/1/1990


2.		Phase I Trial of Tetraplatin in Patients with Solid Tumors and Lymphomas (Summary Last Modified 12/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				over 18				NCI				NCI-90-C-129A WRAMC-9010, NCI-T90-0014N, T90-0014

Last Modified: 9/1/1991


3.		Phase I Study of Tetraplatin in Patients with Advanced Cancer (Summary Last Modified 09/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				WCCC-CO-9092 NCI-T90-0052C, T90-0052

Last Modified: 7/1/1991


4.		Phase I Study of Tetraplatin in Patients with Advanced Solid Tumors (Summary Last Modified 07/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				FCCC-91013 NCI-T90-0224D, T90-0224

Last Modified: 8/1/1991


5.		Phase I Study of Tetraplatin Administered as a 30-Minute Daily Infusion for 5 Days in Patients with Advanced Cancer (Summary Last Modified 08/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				DU-ET-9102 NCI-T91-0043D, T91-0043

Last Modified: 8/1/1993


6.		Phase I Trial of Intraperitoneal Tetraplatin in Patients with Malignancies Involving the Peritoneal Cavity (Summary Last Modified 08/93)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				UCSD-91285 NCI-T91-0111D, T91-0111

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute